The Pennant Group, Inc.
NASDAQ:PNTGMedical - Care Facilities
-$0.83 today
- Market cap
- $1.26B
- Beta
- 1.27
- P/E (TTM)
- 38.6
- EPS (TTM)
- $0.87
Volume 0.43M
Average 0.25M
PNTG Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
The Pennant Group, Inc.NASDAQ: PNTG
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock broadly unchanged from a year ago
Common stock stood at $35K at the end of Q1 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +6.5% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 35K USD
- Year-over-year change
- +0.0%
- 4-year CAGR
- +5.7%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 35K | +0.0% |
| FY2024 | 2024-12-31 | 35K | +20.7% |
| FY2023 | 2023-12-31 | 29K | +0.0% |
| FY2022 | 2022-12-31 | 29K | +3.6% |
| FY2021 | 2021-12-31 | 28K | — |
Common Stock vs competitors
How PNTG compares with its peers on the latest reported figures
- PNTG's Mar 2026 common stock of $35K is the 10th highest of the 11 companies compared; the peer median is $316K.
- Its year-over-year change of +0.0% is the 10th highest of 11, against a peer median of +1.0%.
- Common stock amounts to 0.0% of total assets for PNTG, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $37.61M | +0.1% | +0.7% | 2.4% | |
| Sep 2026 | $2.49M | +0.5% | +7.9% | 0.0% | |
| Oct 2026 | $2.18M | +4.5% | +3.8% | 0.1% | |
| Jun 2026 | $1.2M | +0.0% | +2.9% | 0.0% | |
| Mar 2026 | $474K | +150.8% | +41.0% | 0.0% | |
| Jun 2026 | $158K | +0.6% | +6.8% | 0.0% | |
| Sep 2026 | $156K | +1.3% | +0.4% | 0.0% | |
| Mar 2026 | $137K | +0.7% | +0.2% | 0.0% | |
| Jun 2026 | $62K | +1.6% | +1.7% | 0.0% | |
| Mar 2026 | $35K | +0.0% | +6.5% | 0.0% | |
| Jun 2026 | $19K | +5.6% | +4.0% | 0.0% | |
| Peer median (excluding PNTG) | $316K | +1.0% | +3.4% | 0.0% | |
Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5.19M | 2.08M | 6.06M | 24.25M | 17.02M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 53.94M | 53.42M | 61.12M | 81.3M | 123.11M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 16.71M | 18.32M | 12.9M | 17.31M | 27.27M |
| Total Current Assets | 75.84M | 73.82M | 80.08M | 122.86M | 167.41M |
| Property, Plant & Equipment (Net) | 317.79M | 287.49M | 291.52M | 313.88M | 336.93M |
| Goodwill | 74.27M | 79.5M | 91.01M | 129.12M | 237.25M |
| Intangible Assets | 53.73M | 58.62M | 67.74M | 96.18M | 199.44M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 3.85M | 2.15M | 0 | 0 | 478K |
| Other Non-current Assets | 4.83M | 10.55M | 9.34M | 17.48M | 26.68M |
| Total Non-current Assets | 454.46M | 438.3M | 459.61M | 556.67M | 800.77M |
| Total Assets | 530.3M | 512.12M | 539.69M | 679.52M | 968.18M |
| Account Payables | 10.55M | 13.65M | 10.84M | 18.74M | 25.17M |
| Short-term Debt | 0 | 0 | 0 | 0 | 5M |
| Tax Payables | 1.1M | 1.03M | 1.26M | 1.03M | 0 |
| Deferred Revenue | 7.67M | 1.59M | 1.66M | 2.28M | 2.29M |
| Other Current Liabilities | 13.82M | 1.48M | 780K | 705K | 477K |
| Total Current Liabilities | 71.64M | 70.25M | 71.55M | 101.7M | 147.26M |
| Long-term Debt | 51.37M | 62.89M | 63.91M | 0 | 168.84M |
| Deferred Tax Liabilities | 88.21M | 0 | 1.86M | 1.86M | 150K |
| Deferred Revenue (Non-current) | (88.21M) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.29M | 6.28M | 8.26M | 10.58M | 23.37M |
| Total Non-current Liabilities | 344.42M | 316.22M | 322.63M | 265.86M | 446.66M |
| Total Liabilities | 416.05M | 386.46M | 394.18M | 367.56M | 593.93M |
| Common Stock | 28K | 29K | 29K | 35K | 35K |
| Retained Earnings | 14.64M | 21.28M | 34.66M | 57.22M | 86.8M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4.05M | 4.65M | 5.18M | 18.68M | 41.65M |
| Total Equity | 114.24M | 125.66M | 145.52M | 311.97M | 374.25M |
| Total Debt | 355.24M | 326.57M | 329.63M | 273.09M | 453.16M |
| Net Debt | 350.05M | 324.49M | 323.57M | 248.85M | 436.14M |
The Pennant Group, Inc.
NASDAQ:PNTG
Intrinsic Alpha fair value
Locked
Current Price
$35.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.